Park Avenue Securities LLC Novartis Ag Transaction History

Park Avenue Securities LLC

  • $10.9 Billion
  • Q2 2025

A detailed history of Park Avenue Securities LLC transactions in Novartis Ag stock. As of the latest transaction made, Park Avenue Securities LLC holds 55,319 shares of NVS stock, worth $6.34 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
55,319
Previous 46,508 18.95%
Holding current value
$6.34 Million
Previous $5.19 Million 29.1%
% of portfolio
0.06%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 14, 2025
BUY
$101.96 - $121.01 $898,369 - $1.07 Million
8,811 Added 18.95%
55,319 $6.69 Million
Q1 2025

Apr 14, 2025
BUY
$97.14 - $115.57 $328,430 - $390,742
3,381 Added 7.84%
46,508 $5.19 Million
Q4 2024

Jan 14, 2025
BUY
$96.78 - $117.18 $994,511 - $1.2 Million
10,276 Added 31.28%
43,127 $4.2 Million
Q3 2024

Oct 03, 2024
SELL
$106.13 - $120.89 $173,098 - $197,171
-1,631 Reduced 4.73%
32,851 $3.78 Million
Q2 2024

Jul 09, 2024
BUY
$92.57 - $107.37 $635,215 - $736,772
6,862 Added 24.84%
34,482 $3.67 Million
Q1 2024

Apr 10, 2024
SELL
$95.27 - $108.47 $428,905 - $488,331
-4,502 Reduced 14.02%
27,620 $2.67 Million
Q4 2023

Jan 10, 2024
BUY
$92.27 - $101.54 $188,138 - $207,040
2,039 Added 6.78%
32,122 $3.24 Million
Q3 2023

Oct 26, 2023
BUY
$94.73 - $105.13 $136,600 - $151,597
1,442 Added 5.03%
30,083 $3.06 Million
Q2 2023

Jul 14, 2023
BUY
$92.52 - $104.91 $464,080 - $526,228
5,016 Added 21.23%
28,641 $2.89 Million
Q1 2023

Apr 18, 2023
SELL
$80.03 - $92.81 $17,526 - $20,325
-219 Reduced 0.92%
23,625 $2.17 Million
Q4 2022

Jan 24, 2023
BUY
$75.55 - $92.52 $233,525 - $285,979
3,091 Added 14.89%
23,844 $0
Q3 2022

Nov 01, 2022
BUY
$74.61 - $87.26 $105,125 - $122,949
1,409 Added 7.28%
20,753 $1.58 Million
Q2 2022

Jul 27, 2022
BUY
$80.52 - $93.75 $225,617 - $262,687
2,802 Added 16.94%
19,344 $1.64 Million
Q1 2022

Apr 29, 2022
BUY
$80.11 - $90.62 $191,302 - $216,400
2,388 Added 16.87%
16,542 $1.45 Million
Q4 2021

Apr 08, 2022
SELL
$79.7 - $88.13 $123,056 - $136,072
-1,544 Reduced 9.84%
14,154 $1.24 Million
Q3 2021

Oct 21, 2021
BUY
$81.78 - $95.14 $66,568 - $77,443
814 Added 5.47%
15,698 $1.28 Million
Q2 2021

Aug 05, 2021
BUY
$85.24 - $94.15 $33,925 - $37,471
398 Added 2.75%
14,884 $1.36 Million
Q1 2021

Apr 28, 2021
BUY
$83.5 - $98.47 $12,274 - $14,475
147 Added 1.03%
14,486 $1.24 Million
Q4 2020

Jan 20, 2021
BUY
$78.07 - $94.43 $40,284 - $48,725
516 Added 3.73%
14,339 $1.35 Million
Q3 2020

Nov 03, 2020
BUY
$82.14 - $91.0 $56,183 - $62,244
684 Added 5.21%
13,823 $1.2 Million
Q2 2020

Jul 30, 2020
BUY
$80.93 - $91.1 $285,601 - $321,491
3,529 Added 36.72%
13,139 $1.15 Million
Q1 2020

Apr 28, 2020
BUY
$70.67 - $99.01 $32,084 - $44,950
454 Added 4.96%
9,610 $792,000
Q4 2019

Feb 04, 2020
BUY
$84.35 - $95.37 $103,160 - $116,637
1,223 Added 15.42%
9,156 $867,000
Q3 2019

Oct 18, 2019
BUY
$85.54 - $94.26 $127,711 - $140,730
1,493 Added 23.18%
7,933 $689,000
Q2 2019

Jul 26, 2019
BUY
$75.4 - $92.8 $94,551 - $116,371
1,254 Added 24.18%
6,440 $588,000
Q1 2019

May 02, 2019
BUY
$75.32 - $86.15 $131,282 - $150,159
1,743 Added 50.62%
5,186 $496,000
Q4 2018

Jan 29, 2019
BUY
$73.66 - $82.02 $43,827 - $48,801
595 Added 20.89%
3,443 $302,000
Q3 2018

Nov 05, 2018
SELL
$66.94 - $77.43 $24,566 - $28,416
-367 Reduced 11.42%
2,848 $246,000
Q2 2018

Jul 30, 2018
BUY
$64.91 - $73.36 $208,685 - $235,852
3,215 New
3,215 $240,000

Others Institutions Holding NVS

# of Institutions
1,539
Shares Held
141M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $246B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email